Gareth Morgan Investments Limited Partnership trimmed its stake in shares of Cigna Corporation (NYSE:CI) by 23.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,763 shares of the health services provider’s stock after selling 9,205 shares during the quarter. Gareth Morgan Investments Limited Partnership’s holdings in Cigna Corporation were worth $4,982,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Guardian Life Insurance Co. of America boosted its holdings in shares of Cigna Corporation by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after acquiring an additional 7 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its holdings in shares of Cigna Corporation by 1.1% in the 1st quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after acquiring an additional 22 shares in the last quarter. Wetherby Asset Management Inc. boosted its holdings in shares of Cigna Corporation by 0.8% in the 2nd quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock worth $702,000 after acquiring an additional 33 shares in the last quarter. Cadence Capital Management LLC boosted its holdings in shares of Cigna Corporation by 0.3% in the 2nd quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock worth $1,607,000 after acquiring an additional 33 shares in the last quarter. Finally, Winslow Evans & Crocker Inc. boosted its holdings in shares of Cigna Corporation by 1.9% in the 2nd quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after acquiring an additional 34 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/06/gareth-morgan-investments-limited-partnership-sells-9205-shares-of-cigna-corporation-ci.html.

Shares of Cigna Corporation (NYSE CI) traded down 1.935% during mid-day trading on Wednesday, hitting $181.725. 278,602 shares of the company’s stock traded hands. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $185.51. The firm has a 50-day moving average of $176.85 and a 200 day moving average of $163.29. The company has a market cap of $45.75 billion, a PE ratio of 20.967 and a beta of 0.43.

Cigna Corporation (NYSE:CI) last issued its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. The company had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.98 earnings per share. Equities research analysts predict that Cigna Corporation will post $10.02 EPS for the current year.

In other news, insider Michael W. Triplett sold 1,439 shares of Cigna Corporation stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $166.89, for a total transaction of $240,154.71. Following the transaction, the insider now owns 26,199 shares in the company, valued at $4,372,351.11. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Lisa R. Bacus sold 2,236 shares of Cigna Corporation stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $179.95, for a total transaction of $402,368.20. Following the transaction, the executive vice president now owns 18,501 shares in the company, valued at approximately $3,329,254.95. The disclosure for this sale can be found here. In the last quarter, insiders have sold 223,781 shares of company stock worth $38,470,603. 1.30% of the stock is owned by company insiders.

Several research analysts have recently commented on the company. BidaskClub raised Cigna Corporation from a “buy” rating to a “strong-buy” rating in a report on Friday, August 18th. Morgan Stanley boosted their target price on Cigna Corporation from $188.00 to $195.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Royal Bank Of Canada reissued a “buy” rating and issued a $185.00 target price on shares of Cigna Corporation in a report on Wednesday, August 9th. Zacks Investment Research downgraded Cigna Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th. Finally, Citigroup Inc. boosted their target price on Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a report on Monday, August 7th. Three research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $180.44.

Cigna Corporation Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.